Group One Trading
TRAW icon

Group One Trading’s Traws Pharma TRAW Stock Holding History

Group One Trading’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,164
Closed -$10.3K – 8506
2024
Q4 		$10.3K Buy
1,164
+1,100
+1,719% +$6.12K ﹤0.01% 6086
2024
Q3 		$376 Sell
64
-1
-2% -$9 ﹤0.01% 6410
2024
Q2 		$721 Hold
65
– – ﹤0.01% 6411
2024
Q1 		$1.63K Hold
65
– – ﹤0.01% 6528
2023
Q4 		$1.2K Hold
65
– – ﹤0.01% 6957
2023
Q3 		$1.16K Hold
65
– – ﹤0.01% 7192
2023
Q2 		$1.9K Hold
65
– – ﹤0.01% 7108
2023
Q1 		$1.18K Sell
65
-92
-59% -$1.99K ﹤0.01% 6757
2022
Q4 		$2.52K Buy
157
+8
+5% +$151 ﹤0.01% 6575
2022
Q3 		$3K Hold
149
– – ﹤0.01% 7059
2022
Q2 		$5K Hold
149
– – ﹤0.01% 7145
2022
Q1 		$7K Sell
149
-4
-3% -$185 ﹤0.01% 7328
2021
Q4 		$10K Sell
153
-91
-37% -$7.32K ﹤0.01% 7364
2021
Q3 		$23K Buy
+244
New +$31.4K ﹤0.01% 7098
2015
Q3 		– Hold
0
– – – 5252
2015
Q2 		– Hold
0
– – – 4513
2015
Q1 		– Hold
0
– – – 4327
2014
Q4 		– Hold
0
– – – 4420
2014
Q3 		– Hold
0
– – – 3754
2014
Q2 		– Hold
0
– – – 3588

Other funds holding TRAW

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Group One Trading's TRAW Position: Q1 2025 in Review

Group One Trading sold out of Traws Pharma (TRAW) in Q1 2025, closing a stake of 1,164 shares — an estimated $10.3K sold.

Group One Trading first reported a position in TRAW in Q3 2021 and held it in 14 quarters. The position peaked at $23K in Q3 2021. 19 funds tracked by Wall St. Rank hold TRAW as of Q1 2025.

  • Group One Trading reported no remaining Traws Pharma position as of Q1 2025 after selling out during the quarter.
  • Group One Trading sold 1,164 Traws Pharma shares in Q1 2025, an estimated $10.3K.
  • Group One Trading first reported a position in Traws Pharma in Q3 2021 and held it in 14 quarters.
  • Group One Trading's Traws Pharma position peaked at $23K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2025.

Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.